14 June 2026 in Dentistry: Theory and Practice
Background. Dental implantation is the gold standard for rehabilitation of patients with partial and complete tooth loss. The surface condition of implants is a key determinant of long-term survival — both at placement (in terms of roughness and biocompatibility) and at late stages when inflammatory complications arise. Laser technologies occupy a prominent place among methods of implant surface modification and decontamination. Objective. To analyze data on the use of different laser types for primary dental implant surface treatment and decontamination in peri-implantitis, and to assess the pattern of micro-relief damage at various laser parameters. Materials and methods. An in vitro experimental study was conducted using scanning electron microscopy (SEM) of dental implant surfaces (Straumann, Astra Tech, Osstem, Alpha Bio) following exposure to a diode laser «LSP-IRE-Polyus» (970 nm) and a Nd:YAG laser at power settings of 1 W and 2 W. Surface damage was graded on a 0–5-point scale. Results. The 970 nm diode laser at 1 W caused no damage to any of the studied implant surfaces (0 points), comparable to the pre-experimental intact surface. At 2 W, minor micro-relief disruptions (1–2 points) were detected only in Osstem and Alpha Bio implants. In contrast, the Nd:YAG laser at 1 W caused severe surface damage to all implants (2–5 points), including complete micro-relief disruption, delamination, and visible cracks. At 2 W, the damage was catastrophic. Conclusion. The 970 nm diode laser at 1 W provides effective bactericidal action with minimal implant surface damage and can be recommended for clinical use in peri-implantitis treatment. The Nd:YAG laser at equivalent parameters is not recommended due to significant structural surface damage.
30 December 2025 in Dentistry: Theory and Practice
Gingival recession is a common clinical condition that leads to aesthetic dissatisfaction and dental hypersensitivity. Traditional surgical methods for soft tissue augmentation, while effective, are often invasive and require harvesting autogenous grafts. The search for minimally invasive alternatives has led to growing interest in injectable collagen-based biomaterials. Aim — to evaluate the clinical efficacy and safety of a xenogeneic collagen gel, “Collost,” for increasing soft tissue volume in the treatment of multiple gingival recessions. A 42-year-old female patient with multiple gingival recessions in the maxillary anterior region was treated. After initial professional hygiene, a 7% bovine collagen gel was injected into the soft tissues adjacent to the recessions according to a precise protocol, involving multiple injection points per tooth. A second injection was performed after 1 month to consolidate the result. Clinical outcomes were assessed immediately, at 2 weeks, and over a 12-month follow-up period. The procedure resulted in a significant increase in soft tissue volume and the elimination of gingival recessions, with a stable aesthetic outcome observed throughout the 12-month follow-up period. No adverse events, such as allergic reactions, inflammation, or material rejection, were reported. The protocol demonstrated good patient tolerance and a high safety profile. The use of xenogeneic collagen gel “Collost” is an effective and safe minimally invasive method for soft tissue augmentation in the treatment of gingival recessions. It provides a stable long-term result and represents a promising alternative to more invasive surgical techniques.